Pelthos Therapeutics Inc. PTHS Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $31.98M+24,250% | $17.97M+3,404% | $14.2M+1,032% | $59.17K-97.5% | $131.32K-96.5% | ||
| —— | —— | —— | —— | $0— | ||
| —— | —— | —— | —— | $0— | ||
| $69.8M+7,561% | $53.41M+3,801% | $49.76M+2,225% | $822.85K— | $911.18K— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $145.38M+15,855% | $130.4M+9,425% | $126.43M+5,808% | $822.85K— | $911.18K— | ||
| $6.15M+136% | $2.99M+57.4% | $5.67M+343% | $4.99M— | $2.6M— | ||
| —— | —— | —— | —— | —— | ||
| $25M+390% | $25.99M+537% | $24.77M+594% | $7.32M— | $5.11M— | ||
| —— | —— | —— | —— | —— | ||
| $110.28M+2,059% | $91.52M+2,141% | $68.18M+1,811% | $7.32M— | $5.11M— | ||
| 200M+32,206,019% | 200M— | 200M0.0% | 200M— | 621— | ||
| -$75.03M-220% | -$64.79M-202% | -$43.13M-121% | -$26.89M— | -$23.44M— | ||
| $35.1M+937% | $38.88M+1,533% | $58.25M+4,179% | -$6.49M-3,429% | -$4.2M-471% | ||
| $145.38M+15,855% | $130.4M+9,425% | $126.43M+5,808% | $822.85K— | $911.18K— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Pelthos Therapeutics Inc.'s total assets?
- Pelthos Therapeutics Inc. (PTHS) holds $145.4M in total assets, up 15854.9% year over year.
- How much debt does Pelthos Therapeutics Inc. have?
- Pelthos Therapeutics Inc. carries $29.6M in total debt against $35.1M of shareholders' equity, a debt-to-equity ratio of 0.84.
- How much cash does Pelthos Therapeutics Inc. have?
- Pelthos Therapeutics Inc. holds $32.0M in cash and equivalents.
- Can Pelthos Therapeutics Inc. cover its short-term obligations?
- Its current ratio is 2.79 — current assets exceed current liabilities.
- Where does Pelthos Therapeutics Inc.'s balance sheet data come from?
- Every line is extracted from Pelthos Therapeutics Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
